TY - JOUR
T1 - Neuropharmacology involvement of dopamine D3 receptor in impulsive choice decision-making in male rats
AU - Shen, Hui
AU - Ma, Zilu
AU - Hans, Emma
AU - Duan, Ying
AU - Bi, Guo Hua
AU - Chae, Yurim C.
AU - Bonifazi, Alessandro
AU - Battiti, Francisco O.
AU - Newman, Amy Hauck
AU - Xi, Zheng Xiong
AU - Yang, Yihong
N1 - Publisher Copyright:
© 2024 Elsevier Ltd
PY - 2024/10/1
Y1 - 2024/10/1
N2 - Impulsive decision-making has been linked to impulse control disorders and substance use disorders. However, the neural mechanisms underlying impulsive choice are not fully understood. While previous PET imaging and autoradiography studies have shown involvement of dopamine and D2/3 receptors in impulsive behavior, the roles of distinct D1, D2, and D3 receptors in impulsive decision-making remain unclear. In this study, we used a food reward delay-discounting task (DDT) to identify low- and high-impulsive rats, in which low-impulsive rats exhibited preference for large delayed reward over small immediate rewards, while high-impulsive rats showed the opposite preference. We then examined D1, D2, and D3 receptor gene expression using RNAscope in situ hybridization assays. We found that high-impulsive male rats exhibited lower levels of D2 and D3, and particularly D3, receptor expression in the nucleus accumbens (NAc), with no significant changes in the insular, prelimbic, and infralimbic cortices. Based on these findings, we further explored the role of the D3 receptor in impulsive decision-making. Systemic administration of a selective D3 receptor agonist (FOB02-04) significantly reduced impulsive choices in high-impulsive rats but had no effects in low-impulsive rats. Conversely, a selective D3 receptor antagonist (VK4-116) produced increased both impulsive and omission choices in both groups of rats. These findings suggest that impulsive decision-making is associated with a reduction in D3 receptor expression in the NAc. Selective D3 receptor agonists, but not antagonists, may hold therapeutic potentials for mitigating impulsivity in high-impulsive subjects.
AB - Impulsive decision-making has been linked to impulse control disorders and substance use disorders. However, the neural mechanisms underlying impulsive choice are not fully understood. While previous PET imaging and autoradiography studies have shown involvement of dopamine and D2/3 receptors in impulsive behavior, the roles of distinct D1, D2, and D3 receptors in impulsive decision-making remain unclear. In this study, we used a food reward delay-discounting task (DDT) to identify low- and high-impulsive rats, in which low-impulsive rats exhibited preference for large delayed reward over small immediate rewards, while high-impulsive rats showed the opposite preference. We then examined D1, D2, and D3 receptor gene expression using RNAscope in situ hybridization assays. We found that high-impulsive male rats exhibited lower levels of D2 and D3, and particularly D3, receptor expression in the nucleus accumbens (NAc), with no significant changes in the insular, prelimbic, and infralimbic cortices. Based on these findings, we further explored the role of the D3 receptor in impulsive decision-making. Systemic administration of a selective D3 receptor agonist (FOB02-04) significantly reduced impulsive choices in high-impulsive rats but had no effects in low-impulsive rats. Conversely, a selective D3 receptor antagonist (VK4-116) produced increased both impulsive and omission choices in both groups of rats. These findings suggest that impulsive decision-making is associated with a reduction in D3 receptor expression in the NAc. Selective D3 receptor agonists, but not antagonists, may hold therapeutic potentials for mitigating impulsivity in high-impulsive subjects.
KW - D3 receptor
KW - D3 receptor agonist
KW - D3 receptor antagonist
KW - Decision-making
KW - Dopamine
KW - FOB02-04
KW - Impulsive choice
KW - Impulsivity
KW - Reward delay discounting task
KW - VK4-116
UR - http://www.scopus.com/inward/record.url?scp=85197804140&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85197804140&partnerID=8YFLogxK
U2 - 10.1016/j.neuropharm.2024.110051
DO - 10.1016/j.neuropharm.2024.110051
M3 - Article
C2 - 38917939
AN - SCOPUS:85197804140
SN - 0028-3908
VL - 257
JO - Neuropharmacology
JF - Neuropharmacology
M1 - 110051
ER -